Jeffrey A. Bailey
Board Member
Aurinia Pharmaceuticals Inc. (AUPH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey A. Bailey
Jeffrey A. Bailey is recorded as Board Member at Aurinia Pharmaceuticals Inc. (AUPH). Aurinia Pharmaceuticals Inc. reported in an 8-K filed May 15, 2025 that Jeffrey A. Bailey was appointed members of the Company's board of directors, effective May 15, 2025. Aurinia Pharmaceuticals Inc. reported in an 8-K filed August 21, 2023 that Jeffrey A. Bailey was appointed Board of Directors, effective August 18, 2023.
“the shareholders elected Mr. Kevin Tang, Mr. Jeffrey A. Bailey, Ms. Kathy L. Goetz, Mr. Peter Greenleaf, Mr. Craig Johnson and Ms. Tina S. Nova to serve as members of the Company's board of directors until the annual general meeting of shareholders to be held in 2026.”
“Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia's Board of Directors August 18, 2023”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-15–present
-
Start not stated–2024-05-03
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aurinia Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Michael Hearne CFO
- Matthew Donley COO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Karen Smith Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.